Lesson series
Clinical Evaluation under MDR
This beginner-level Clinical Evaluation course provides a structured introduction to the key principles and regulatory expectations governing clinical evaluation in the medical device industry. Participants are guided through the full clinical data lifecycle under the MDR, with a strong focus on how clinical evidence is generated, assessed, and maintained throughout a device’s lifetime.
Format
Online
Course
Starting date
August 4th, 2026
Available for
6 months
Duration
14 sessions
Level
Beginner
Why you should join this course?
What can you expect?
The course covers fundamental concepts such as benefit-risk analysis and the role it plays in demonstrating device safety and performance. It explores multiple strategies for clinical evaluations, including approaches based on clinical investigations, equivalent devices, and non-clinical data, enabling participants to understand when and how each method is applied. Core standards such as ISO 18969 are introduced to contextualize regulatory requirements.
Practical aspects are emphasized through sessions on vigilance data searches, post-market surveillance (PMS) data, and the identification and use of different types of clinical studies and publications. Participants learn how to perform effective literature searches, conduct state-of-the-art analyses, and critically analyze clinical data.
The course also provides detailed guidance on the preparation of Clinical Evaluation Plans (CEP) and Clinical Evaluation Reports (CER), along with insights into the notified body review process and common deficiencies observed during assessments. It concludes with a recap of key concepts and an overview of Post-Market Clinical Follow-up (PMCF) and other relevant legislation, ensuring participants have a comprehensive foundation to begin working in clinical affairs.
What's included?
14 Sessions by experienced professionals from industry, notified body and academia
Clinical Data & MDR / Lifecycle
Benefit-Risk Analysis
Strategies for Clinical Evaluations
Literature Search and Documentation
State-of-the-Art and Available Knowledge
MDCG Guidances and ISO 18969
Vigilance Data Search, PMS Data
Notified Body: Review process and typical issues observed
Self-funded*
Early Bird
250€
Normal Price: 300€
Corporate
Early Bird
500€
Normal Price: 750€
Student**
200€
What can you expect?
Across 14 interactive 90-minute sessions, participants gain a structured and practical introduction to Regulatory Affairs for medical devices. Each webinar includes a 45–60 minute presentation, followed by live Q&A to foster exchange and clarity
The program is designed for those planning a career in regulatory affairs as well as professionals in startups or MedTech companies who are newly responsible for regulatory activities.
Meet the Speakers
Michael D'Agosto
MODERATOR
Michael D’Agosto is Professor and Dean of Studies M.Sc. Medical Devices - Regulatory Affairs at Hochschule Furtwangen University. He is a medical doctor (MD) and medical engineer by training and worked in the medical device industry prior to his academic career. Michael is also Scientific Expert and Partner at Escentia GmbH. Michael has been part of Edvance MedTech from the very beginning, sharing his expertise and experience. He is essential for our progression with his ability to explain complex issues in a comprehensible way and for his openness to support everyone.
Cécile van der Heijden
MODERATOR
Cécile van der Heijden is an attorney-at-law at Axon Lawyers and strategist in European life sciences regulation, with expertise spanning MedTech, AI, data, biotech and health law. Her special interest lies with cross-legislation and FemTech. Recognised for her cross-legislation expertise, she brings coherence to complex regulatory frameworks. She is a frequent speaker at international conferences and has published on medical devices, data governance, and health law, as well as on history, combining professional practice with academic inquiry.
Elisabeth Oltmanns
MODERATOR
Elisabeth Oltmanns is a PhD student and her research focuses on the integration of clinical and non-clinical data (eclipse-md.com). With a background in Biomedical Engineering and an MSc in Regulatory Affairs, she combines technical expertise with regulatory insight. Alongside her academic work, she consults through Escentia, a boutique clinical affairs consultancy supporting medium-risk medical devices. Passionate about advancing medical device development, she is dedicated to transforming clinical evaluations from a regulatory requirement into a strategic advantage.
Yu Jin
MDR CLINICAL EXPERT
Yu Jin is a clinical and regulatory affairs specialist with an MD and PhD in cardiology and cardiovascular epidemiology. With over 15 years of experience across clinical practice, research, the medical device industry, and regulatory sectors, Dr. Jin has developed a comprehensive understanding of both the clinical and scientific aspects of medical device development and evaluation. Currently a consultant, her career has included leadership roles in clinical and regulatory strategy, particularly in the areas of EU MDR clinical evaluations and clinical investigations. Dr. Jin has extensive expertise in the Notified Body conformity assessment process, including Clinical Evaluation Reports (CER), Post-Market Clinical Follow-up (PMCF) studies, and clinical investigations.An author of over 50 peer-reviewed scientific publications, Dr. Jin is also recognised for her deep clinical expertise in cardiovascular devices.
And more...
Our students say
Excellent speakers, interesting discussions, fun and great atmosphere.
andrea
Your initiative is inspiring, with a great delivery and perfect timing. The team is welcoming and shows a very serious intent to find and propose ways of sailing through the realities imposed by
the MDR and its implementation...
Bruno Oliviera, cmo
It is a very interesting and informative course, excellent trainers/speakers.
peter
Offer for Teams
Send more people from your team and get up to 40 % discount!
25% of team (min. 2) —> 10% discount
50% of team (min. 3) —> 20% discount
75% of team (min. 4) —> 30% discount
Full team (min 5) —> 40% discount
Self-funded*
???
Corporate
???
Student**
???
